Korean J Urol.  2006 Feb;47(2):124-130. 10.4111/kju.2006.47.2.124.

Pattern of Recurrence and the Prognostic Factors of Upper Urinary Tract Transitional Cell Carcinoma

Affiliations
  • 1Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea. youngd74@yumc.yonsei.ac.kr
  • 2Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

Abstract

PURPOSE: We evaluated the pattern of recurrence and the prognostic factors for patients who suffered with upper urinary tract transitional cell carcinoma (TCCa) and were surgically treated.
MATERIALS AND METHODS
Between 1986 and 2003, the medical records on 228 patients who were diagnosed and surgically treated for upper urinary tract TCCa were retrospectively analyzed with regard to the pattern of recurrence and the prognostic factors. The main site of the tumors was the renal pelvis in 127 patients and the ureter in 101 patients. Nephroureterectomy and/or bladder cuff resection was performed on 215 patients and conservative surgery was performed on 13 patients, respectively.
RESULTS
Recurrence developed in 75 patients (32.9%) and the mean time to recurrence was 23.9 months (3-120). Of these 75 patients, locoregional recurrence without metastasis occurred in 28.0%, locoregional recurrence with metastasis occurred in 25.3%, metastasis without locoregional recurrence occurred in 42.7% and contralateral upper tract recurrence occurred in 4%. There was no difference between the renal pelvic cancer and ureteral cancer regarding the pattern of recurrence. Meanwhile, 5-year recurrence-free and disease-specific survival rates were 63.9% and 69.7%, respectively. On univariate analysis, the T stage, tumor grade, lymphovascular permeation, margin status and nodal status had a significant influence on recurrence-free survival and disease-specific survival. On multivariate analysis, the T stage and lymphovascular permeation were independent prognostic factors for upper urinary tract TCCa.
CONCLUSIONS
Locoregional recurrence and metastasis frequently occurred in the upper urinary tract TCCa irrespective of the tumor location. The T stage and lymphovascular permeation were independent prognostic factors for the upper urinary tract TCCa.

Keyword

Transitional cell carcinoma; Ureter; Kidney pelvis; Recurrence; Prognosis

MeSH Terms

Carcinoma, Transitional Cell*
Humans
Kidney Pelvis
Medical Records
Multivariate Analysis
Neoplasm Metastasis
Pelvic Neoplasms
Prognosis
Recurrence*
Retrospective Studies
Survival Rate
Ureter
Ureteral Neoplasms
Urinary Bladder
Urinary Tract*

Figure

  • Fig. 1. Overall disease-specific survival probabilities for the patients with upper urinary tract transitional cell carcinoma.

  • Fig. 2. Overall disease-specific survival probabilities for the patients with upper urinary tract transitional cell carcinoma according to the T stages.

  • Fig. 3. Overall disease-specific survival probabilities for the patients with upper urinary tract transitional cell carcinoma according to the lymphovascular permeation. LV: lymphovascular permeation.

  • Fig. 4. Overall disease-specific survival probabilities for the patients with upper urinary tract transitional cell carcinoma according to the tumor location.


Cited by  2 articles

Correlation of Cyclooxygenase-2 Expression and Microvessel Density with Prognosis in Transitional Cell Carcinoma of the Upper Urinary Tract
Min Ho Cha, Dae Sung Cho, Hyunee Yim, Kang Su Cho, Sung Joon Hong, Nam Hoon Cho, Sun Il Kim, Hyun Soo Ahn, Se Joong Kim
Korean J Urol. 2007;48(4):376-382.    doi: 10.4111/kju.2007.48.4.376.

The Patterns and Risk Factors for Subsequent Bladder Recurrence in Patients with Transitional Cell Carcinoma of the Upper Urinary Tract: A Long-Term Follow-Up Study
Hyun Min Choi, Kang Su Cho, Sung Yong Cho, Young Deuk Choi, Byung Ha Chung, Sung Joon Hong
Korean J Urol. 2008;49(4):294-299.    doi: 10.4111/kju.2008.49.4.294.


Reference

1.Tawfiek ER., Bagley DH. Upper-tract transitional cell carcinoma. Urology. 1997. 50:321–9.
Article
2.Hall MC., Womack S., Sagalowsky AI., Carmody T., Erickstad MD., Roehrbom CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998. 52:594–601.
Article
3.Murphy DM., Zincke H., Furlow WL. Primary grade 1 transitional cell carcinoma of the renal pelvis and ureter J Urol. 1980. 123:629–31.
4.Zoretic S., Gonzales J. Primary carcinoma of ureters. Urology. 1983. 21:354–6.
Article
5.Anderstrom C., Johansson SL., Pettersson S., Wahlqvist L. Carcinoma of the ureter: a clinicopa仕Lologic study of 49 cases. J Urol. 1989. 142:280–3.
6.Cozad SC., Smalley SR., Austenfeld M., Noble M., Jennings S., Raymond R. Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. Urology. 1995. 46:796–800.
Article
7.Coirado F., Ferri C., Mannini D., Corrado G., Bertoni F., Bacchini P, et al. Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis. J Urol. 1991. 145:1159–63.
8.Miyake H., Hara I., Gohji K., Arakawa S., Kamidono S. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract. Br J Urol. 1998. 82:494–8.
Article
9.Ozsahin M., Zouhair A., Villa S., Storme G., Chauvet B., Taus-sky D, et al. Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer. 1999. 35:738–43.
Article
10.Park SC., Hong BS., Kim CS., Ahn HJ. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol. 2004. 171:621–5.
Article
11.Mellemgaard A., Carstensen B., Norgaard N., Knudsen JB., Olsen JH. Trends in the incidence of cancer of the kidney, pelvis, ureter and bladder in Denmark 1943-88. Scand J Urol Nephrol. 1993. 27:327–32.
Article
12.Munoz JJ., Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000. 164:1523–5.
Article
13.Heney NM., Nocks BN., Daly JJ., Blitzer PH., Parkhurst EC. Prognostic factors in carcinoma of the ureter. J Urol. 1981. 125:632–6.
Article
14.Komatsu H., Tanabe N., Kubodera S., Maezawa H., Ueno A. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. J Urol. 1997. 157:1622–4.
Article
15.Brookland RK., Richter MP. The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter. J Urol. 1985. 133:952–5.
Article
16.Babaian RJ., Johnson DE., Chan RC. Combination nephroureterectomy and postoperative radiotherapy for infiltrative ureteral carcinoma. Int J Radiat Oncol Biol Phys. 1980. 6:1229–32.
Article
17.Maulard-Durdux C., Dufour B., Hennequin C., Chretien Y., Vignes B., Droz D, et al. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? J Urol. 1996. 155:115–7.
Article
18.Hasui Y., Nishi S., Kitada S., Osada Y., Asada Y. The p, ognostic significance of vascular invasion in upper urinary tract transitional cell carcinoma. J Urol. 1992. 148:1783–5.
19.Davis BW., Hough AJ., Gardner WA. Renal pelvic carcinoma: morphological correlates of metastatic behavior. J Urol. 1987. 137:857–61.
Article
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr